Renu Virmani

CVPath Institute, Gaithersburg, MD, US


Dr. Virmani is an internationally renowned cardiovascular pathologist. She is recognized as a leading researcher in the field of cardiovascular disease treatments.

Currently Dr. Virmani serves as the President of CVPath Institute, which she founded in 2005. Dr. Virmani lectures at scientific meetings, both nationally and internationally, and has delivered more than 800 presentations globally. She is responsible for multiple research grants in the field of cardiovascular pathology and has authored or co-authored over 600 publications in peer-reviewed journals in the field of atherosclerosis, vulnerable plaque, stents, and other cardiovascular diseases. She has edited 7 books and written over 100 book chapters. Dr. Virmani is also a manuscript reviewer for many scientific journals.

Dr. Virmani was recently presented with the 2012 TCT Career Achievement Award by the Cardiovascular Research Foundation. She has also been recognized by the Council on Clinical Cardiology of the American Heart Associations and also delivered the Laennec Clinician Educator Lecture in 2010. She was awarded an honorary degree from the University of Antwerp, Belgium in 2008 and has also received honorary awards from European Society of Cardiology (2008) and EuroPCR (2006).

Dr. Virmani is also Clinical Professor, Department of Pathology at Georgetown University; University of Maryland-Baltimore; George Washington University; and Vanderbilt University. She was a Chairperson at the Department of Cardiovascular Pathology of the Armed Forces Institute of Pathology from 1984 until 2004. Dr. Virmani is a member of the American Heart Association, the U.S. and Canadian Academy of Pathology, and is a Fellow of the American College of Cardiology. Dr. Virmani received her M.D. from Lady Hardinge Medical College, Delhi University, in New Delhi, India.


Dr Renu Virmani

Renu Virmani,

Citation: European Cardiology Review 2018;13(2):134–135.


Renu Virmani,

Citation: Interventional Cardiology 2011;6(2):104

HORIZONS and Drug-eluting Stent Usage in Acute Myocardial Infarction

Gaku Nakazawa, Masataka Nakano, Marc Vorpahl, et al

Citation: Interventional Cardiology 2009;4(1):53-6

Pathology of First-generation Drug-eluting Stents in Humans

Fumiyuki Otsuka, Masataka Nakano, Saami K Yazdani, et al

Citation: Interventional Cardiology 2011;6(1):28–35

Pathology of First-generation Drug-eluting Stents in Humans

Fumiyuki Otsuka, Masataka Nakano, Saami K Yazdani, et al

Citation: Asia-Pacific Cardiology 2011;3(1):52-9

Pre-clinical and Clinical Study Results for the Coracto™ Rapamycin-eluting Stent – A New-generation Drug-eluting Stent

Nicolaus Reifart, Mariann Gyöngyösi, Karl-Eugen Hauptmann, et al

Citation: Interventional Cardiology 2010;5:39–42

Morphologic Predictors of Drug-eluting Stent Thrombosis

Gaku Nakazawa, Aloke V Finn, Renu Virmani, et al

Citation: US Cardiology 2007;4(1):75–6